Category:natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Boiling Point: | 482.87 °C. @ 760.00 mm Hg (est)
|
Flash Point: | 282.00 °F. TCC ( 138.70 °C. ) (est)
|
logP (o/w): | 0.591 (est) |
Soluble in: |
| water, 85.84 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
BOC Sciences |
For experimental / research use only. |
Tetrahydropalmatin >98%
Odor: characteristic Use: Rotundine, that is isolated from the root of Stephania tetrandra S. Moore, has significant effect of analgesia at 15min (P=0.022<0.05) and at 30min (P=0.022<0.05). It is ineffective in 60min. Rotundine may be a useful drug for suppressing morphine tolera
Antinociceptive |
Changsha Organic Herb |
Corydalis Yanhusuo Extract
|
Coompo |
For experimental / research use only. |
Rotundine from Plants ≥98%
Odor: characteristic Use: Rotundine at 20 mg/kg given subcutaneously (s.c.), which by itself did not produce any antinociceptive effect, significantly inhibited the development of tolerance. The physical dependence was evaluated in male rats. The behavioral signs including jumping, wet-dog shakes, teeth chattering, writhing, diarrhea, ptosis and vocalizing on touch, were observed. Withdrawal was precipitated by a single injection of naloxone in dependent rats. Rotundine (20 mg/kg, s.c.) suppressed jumping, teeth chattering, diarrhea and irritability but not other signs of physical dependence in the rat. The psychic dependence was assessed by the conditioned place preference in male mice. Rotundine (20 mg/kg s.c.), significantly attenuated the place preference induced by morphine. The results suggest that rotundine may be a useful drug for suppressing morphine tolerance and withdrawal symptoms.
Rotundine has significant effect of analgesia at 15min (P=0.022<0.05) and at 30min (P=0.022<0.05). It is ineffective in 60min.Rotundine is used for producing tranquilliser with safe sleeping effect and without side-effects. |
Nacalai USA |
For experimental / research use only. |
dl-Tetrahydropalmatine
|
Santa Cruz Biotechnology |
For experimental / research use only. |
L-Tetrahydropalmatine
|
Safety Information:
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intraperitoneal-mouse LD50 100 mg/kg French Medicament Patent Document. Vol. #4818M
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | natural substances and extractives |
Recommendation for tetrahydropalmatine usage levels up to: | | not for fragrance use.
|
|
Recommendation for tetrahydropalmatine flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
| (13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline |
NIST Chemistry WebBook: | Search Inchi |
Pubchem (cid): | 72301 |
Pubchem (sid): | 135076267 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
13a-a- | berbine, 2,3,9,10-tetramethoxy- | | caseanine | (-)- | corydalis | 6H- | dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (S)- | 6H- | dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (13aS)- | 6h- | dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-,(13as)- | | gindarine | | hyndarin | | hyndarine | | rotundine | (S)-5,8,13,13a- | tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine | 5,8,13,13a- | tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine | 5,8,13,13a(S)- | tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a,g]quinolizine | (-)- | tetrahydropalmatine | 2,3,9,10- | tetramethoxy-13aa-berbine | (13aS)-2,3,9,10- | tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline | (S)-2,3,9,10- | tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline | 2,3,9,10- | tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline | (13aS)-2,3,9,10- | tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline | (S)-2,3,9,10- | tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[3,2-a]isoquinoline |
Articles:
|